Efficacy and safety of a 24-day regimen of drospirenone-containing combined oral contraceptive in Korean women
Nayoung Kim, Ha-Na Yoo, Hye Sun Hyun, Dong-Yun Lee, Byung-Koo Yoon, Doo-Seok Choi
Obstet Gynecol Sci. 2015;58(5):397-400.   Published online 2015 Sep 22     DOI: https://doi.org/10.5468/ogs.2015.58.5.397
Citations to this article as recorded by Crossref logo
Safety and Efficacy of Combined Oral Contraceptive Ethinyl Estradiol/Drospirenone (YAZ) in Chinese Women: A Single-Arm, Open-Label, Multicenter, Post-Authorization Study
Xin Sun, Fangbo Qian, Yaojuan He, Xiangying Gu, Wen Di
Advances in Therapy.2020; 37(2): 906.     CrossRef
Progesterone – Friend or foe?
Inger Sundström-Poromaa, Erika Comasco, Rachael Sumner, Eileen Luders
Frontiers in Neuroendocrinology.2020; 59: 100856.     CrossRef
FSRH Guideline (January 2019, amended November 2020) Combined Hormonal Contraception
BMJ Sexual & Reproductive Health.2019; 45(Suppl 1): 1.     CrossRef
Synthetic Hormones and Clot Formation
Albe C. Swanepoel, Amcois Visagie, Etheresia Pretorius
Microscopy and Microanalysis.2016; 22(4): 878.     CrossRef